MENU
ARTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Artelo Biosciences (ARTL) Earnings Date & Reports
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company... Show more
A.I. Advisor
published Earnings
ARTL is expected to report earnings to fall 82.00% to -72 cents per share on August 12
Q2'26
Est.
$-0.72
Q1'26
Missed
by $3.87
Q4'25
Missed
by $1.98
Q3'25
Missed
by $3.83
Q2'25
Missed
by $5.48
The last earnings report on May 14 showed earnings per share of -400 cents, missing the estimate of -12 cents. With 123.69K shares outstanding, the current market capitalization sits at 4.39M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a development stage company, which engages in discovering, licensing, developing and commercializing treatments that modulate the endocannabinoid system.
Industry Biotechnology
Profile
Details
Industry
N/A
Address
505 Lomas Santa Fe
Phone
+1 858 925-7049
Employees
7
Web
https://www.artelobio.com